Larimar Therapeutics Inc.

NASDAQ: LRMR · Real-Time Price · USD
3.97
-0.29 (-6.81%)
At close: Aug 15, 2025, 3:07 PM

Larimar Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.94 -5.41 -3.11 -3.68
PEG Ratio
-0.05 0.15 0.06 0.21
PS Ratio
n/a n/a n/a n/a
PB Ratio
1.38 2.44 0.96 2.88
P/FCF Ratio
-3.33 -5.94 -3.85 -4.36
P/OCF Ratio
-3.35 -5.97 -3.86 -4.4
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.03 0.07 0.05 0.09
Quick Ratio
8.02 9.49 11.28 8.19
Current Ratio
8.02 9.49 11.28 8.16
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.47 -0.45 -0.31 -0.78
Return on Assets
-0.4 -0.39 -0.27 -0.64
Return on Invested Capital
-0.51 -0.48 -0.3 -0.71
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a